cro.directory
← Compare landing

Aldeyra Therapeutics vs MPREX

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/aldeyra/mprex

CategoryAldeyra TherapeuticsMPREX
Listed sitecrocro
SummaryBiopharmaceutical company developing immunomodulatory therapies for immune-mediated ocular and systemic diseases, with late-stage clinical candidates targeting dry eye disease, allergic conjunctivitis, and retinal conditions.MPREX is a contract research organization in Pune, India, specializing in clinical trials in dermatology and claim-substantiation studies for skin and hair care products, with laboratory testing for product efficacy and safety.
Services
  • Phase III Clinical Trials
  • Phase II Clinical Trials
  • Clinical Operations
  • US FDA Regulatory Strategy
  • Immunology & Inflammation Services
  • Clinical Trial Services
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
Modalities
  • Small Molecule
Data not yet provided.
Indications
  • Immunology
  • Rare Disease
  • Ophthalmology
  • Dermatology
LocationsData not yet provided.
  • Headquarters, Pune, India
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.